This article was originally published in The Gray Sheet
Nets approximately $81 mil. from an offering of 3 mil. shares of common stock (2.5 mil. in the U.S. and .5 mil. outside the U.S.) at $28.375 per share. The company initially planned to sell a total of 2.5 mil. shares ("The Gray Sheet" Jan. 4, p. 11). Proceeds will be used for repayment of long-term debt, potential future acquisitions, and general corporate purposes.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.